This funding opportunity supports research to develop innovative screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. It also targets "high priority" genetic conditions where screening is not yet recommended but early detection and treatment could significantly benefit infants. The goal is to improve newborn screening panels by validating accurate tests and demonstrating early intervention benefits.
Open to a wide range of organizations including small businesses, educational institutions, nonprofits, tribal governments, state and local governments, and certain federal agencies. Includes diverse institution types such as HBCUs, AANAPISISs, and faith-based organizations.
